BEIERSDORF |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 140.3 EUR | +0.92% |
|
+3.35% | +3.43% |
| Sales 2024 * | 10.01B 10.74B | Sales 2025 * | 10.57B 11.33B | Capitalization | 31.12B 33.39B |
|---|---|---|---|---|---|
| Net income 2024 * | 978M 1.05B | Net income 2025 * | 1.08B 1.15B | EV / Sales 2024 * | 2.65 x |
| Net cash position 2024 * | 4.63B 4.96B | Net cash position 2025 * | 5.39B 5.78B | EV / Sales 2025 * | 2.44 x |
| P/E ratio 2024 * |
31.7
x | P/E ratio 2025 * |
28.7
x | Employees | 21,958 |
| Yield 2024 * |
0.74% | Yield 2025 * |
0.75% | Free-Float | 38.04% |
More Fundamentals
* Assessed data
More news
Latest transcript on Beiersdorf
More press releases
More news
| 1 day | +0.63% | ||
| 1 week | +2.91% | ||
| Current month | +3.56% | ||
| 1 month | +4.10% | ||
| 3 months | +4.17% | ||
| 6 months | +15.07% | ||
| Current year | +2.98% |
1 week
136.40
139.85
1 month
128.55139.85
Current year
128.55143.90
1 year
113.40143.90
3 years
79.00143.90
5 years
77.62143.90
10 years
60.78143.90
| Managers | Title | Age | Since |
|---|---|---|---|
Vincent Warnery
CEO | Chief Executive Officer | 56 | 17-02-14 |
Astrid Hermann
DFI | Director of Finance/CFO | 51 | 20-12-31 |
Gitta Neufang
CTO | Chief Tech/Sci/R&D Officer | 51 | 02-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Reinhard Pöllath
CHM | Chairman | 76 | 04-06-02 |
Manuela Rousseau
BRD | Director/Board Member | 69 | 99-05-31 |
Wolfgang Herz
BRD | Director/Board Member | 74 | 20-04-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.79% | 79 M€ | -.--% | ||
| 1.02% | 962 M€ | -.--% | - | |
| 0.89% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 140.4 | +0.97% | 97 587 |
| 24-04-25 | 139 | +0.32% | 288,800 |
| 24-04-24 | 138.6 | +0.73% | 290,544 |
| 24-04-23 | 137.6 | +0.88% | 288,391 |
| 24-04-22 | 136.4 | +0.44% | 230,757 |
Delayed Quote Xetra, April 26, 2024 at 06:58 am EDT
More quotes
Beiersdorf Aktiengesellschaft specializes in the development, production and marketing of cosmetic products. Net sales break down by family of products as follows:
- cosmetic products (82.4%): skincare products for the face and body (Nivea Labello, 8x4, SBT, La Prairie, Slek and Florena brands), haircare products (Nivea), plasters and bandages (mainly Hansaplast and Elastoplast), dermatology products (Eucerin);
- adhesive products (17.69%): band-aids, adhesive tape, surgical tape, scotch tape, etc. (Tesa brand).
Net sales are distributed geographically as follows: Europe (44.1%), Africa/ Asia/ Australia (26.3%) and Americas (29.6%).
Sector
Personal Products
Calendar
2024-08-06
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
139
EUR
Average target price
140.4
EUR
Spread / Average Target
+0.99%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.98% | 33.34B | |
| +10.93% | 384B | |
| +8.26% | 128B | |
| +12.02% | 73.4B | |
| -16.59% | 62.92B | |
| -0.86% | 51.98B | |
| -11.66% | 36.42B | |
| +7.40% | 17.19B | |
| +6.30% | 14.76B | |
| -8.65% | 10.77B |
- Stock Market
- Equities
- BEI Stock
